SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Search
Close this search box.

Scientific Committee

Over 20 Subcommittees powering the therapeutics and tech innovation research and initiatives.

Scientific Committee

The Alzheimer’s Disease and Dementia SBMT Subcommittee, focuses on research on novel early diagnostics, therapeutics and management of Alzheimer’s disease and neurodegenerative diseases and dementia.

The Autism and Pediatric Neuroscience SBMT Subcommittee focuses on research on autism spectrum disorder and pediatrics neurological diseases, their implications diagnostics and therapeutics.

The Cerebrovascular and Skull base Surgery SBMT Subcommittee encompasses the divisions of neurosurgery, interventional neuroradiology, and AI endovascular surgery, all of which focus on a multidisciplinary approach to the treatment and care of various neurovascular diseases.

The Epilepsy, EEG, MEG, and NeuroRadiology SBMT Subcommittee, focuses on the functional aspects of neuro-imaging and associated research. MRI, MEG, PET, nuclear medicine, MRSI, MR-PET, DTI, CT-PET, focused ultrasound, MSI/MEG, ultra-high and low field MRI and interventional radiology, neurooncology, SRS, Gamma-Knife, Cyberknife, ZAP.

The Military Medicine and Veterans Health focuses on research regarding health for wounded soldiers and improvement of quality of life. PTSD, Traumatic Brain Injury, Mental Health, Neurotechnology, prosthetics, and Neurotrauma.

The NanoneuroSurgery and NeuroPhotonics SBMT Subcommittee focuses on research on the newest advances on nanotechnology for the purpose of neurosurgery and neurology. This subcommittee also explores the novel phtotonic applications in neurology and neurosciences in general.

The Neurooncology and Stem Cell SBMT Subcommittee, focuses on research on Brain cancer such as Glioblastoma, Astrocytoma and Meningiomas, their early molecular diagnosis, different therapeutic modalities (chemotherapy, radiation oncology, biologics, immunotherapy)

The Neuropsychiatric and Innovation SBMT Subcommittee, focuses on research on addiction, anxiety disorder, autism, sleep, medical imaging for psychiatric conditions, schizophrenia, depression, PTSD.

The Neuroscience20 SBMT Initiative subcommittee focuses on the global economical burden of neurological diseases and formulates resolutions given to the G20 leaders. It also leads an annual summit that is a think tank that serves this purpose, engaging in business plan workshops, health care policy issues that affect treatment delivery, usage of certain devices/drugs/imaging technologies, FDA regulations and reimbursements, federal and regional regulation impacting health care delivery and research funding, initiative and congressional legislation.

The Neurotechnology, Brain Computer Interface and Neuroengineering SBMT Subcommittee is for those who want to see the future, today. It dwells on the latests technological advances applied to neurosciences in general. AI Machine Learning.

The Psychedelics SBMT Subcommittee, focuses on research on the use of psychedelics for diverse neuropsychiatric illnesses.

The Spine Surgery SBMT subcommittee focuses on State-of-the-art diagnostic, surgical tools, and therapeutics. Some topics that we research are:
• Degenerative spine disease
• Spinal deformity (kyphosis/scoliosis)
• Spinal tumors (primary and metastatic bone tumors as well as intradural tumors)
• Spinal trauma
• Osteoporotic and geriatric spinal pathology
• Revision spinal surgery to treat failed fusions or adjacent level pathology
• Intraoperative CT scan and navigation systems
• State-of-the-art neuromonitoring
• CyberKnife radiosurgery
We specialize in traditional open and newer minimally invasive spinal techniques to treat the above pathologies.

The Visual Processing and Retinal Neuromodulation SBMT Subcommittee focuses on research on retinal processing and its impact on modulation
of autonomic, endocrine and limbic functions, visual influence on movement and behavior (including mental health diagnoses), effect of delayed visual development in autism and other developmental disabilities, visual circuitry disruptions from autonomic dysregulation, concussions and other brain injuries, advancements in optical assessments, sensory integration, virtual augmented/mixed reality.

Qifa Zhou

Epilepsy, EEG, MEG and NeuroRadiology Subcommittee SBMT 2023-2024
Professor in the Department of Ophthalmology in the USC Keck School of Medicine as well as the Department of Biomedical Engineering at the University of Southern California.

David Baron, DO, MSEd

2024 GFC Gold Axon Leadership Award WBMF
David Baron, DO, MSEd, is Senior Vice President and Provost of the Western University of Health Sciences and serves as Chief Academic Officer of the university. He is responsible for academic, accreditation, and budgetary affairs.

Giuseppe Umana

Chair of Cerebrovascular advances Subcommittee 2023-2024 | 2023 Award Recipient
Highly rated in 15 conditions, according to our data. His top areas of expertise are Meningioma, Epidural Hematoma, Subdural Hematoma, Laminectomy, and Gamma Knife Radiosurgery.

Lawrence Steinman

2023 WBMF Pioneer in Medicine Award Recipient
Dr. Lawrence Steinman is a professor of Neurology and Neurological Sciences, Pediatrics, and Genetics.  He also served as the Chair of the Stanford University Interdepartmental Program in Immunology from 2003-2011.

Margaret Fahnestock

Alzheimer's Disease and Dementia Subcommittee SBMT 2023- 2024
Margaret Fahnestock is a molecular neurobiologist at McMaster University. She is a professor in the Department of Psychiatry and Behavioural Neurosciences, as well as an Associate Member of the Department of Biology and a member of the Medical Sciences graduate program. Margaret has been working with McMaster since 1991, when she joined the Department of Biomedical Sciences.

Thomas Williams

BCI, Neurotechnology, Neuroengineering Subcommitee 2023-2024
Element Scientist for HFBP. Affiliated with NASA Johnson Space Center (JSC) since 2015, Tom directs a multi-disciplined team of scientists focused on human factors in the areas of habitability, mission processes and tasks, human automation robotic interactions, dynamic loads, and training; as well as spaceflight risks related to behavioral medicine, sleep and fatigue, and team performance.

Kenneth P. Green

Military Medicine and Veteran's Health Subcommittee SBMT 2023-2024 | GPS Project Lead (2023) - Archived
Kenneth P. Green, D.M.D., B.S.

Harry Kloor

2019 Golden Axon Award Recipient
Dr. Harry Kloor is a successful serial entrepreneur, scientist, technologist, educator, policy advisor, author, and Hollywood filmmaker. He is the CEO and Co-Founder of Beyond Imagination; a company that has developed a suite of exponential technology solutions that deploys AI, AR, Robotics, Machine Learning and human-computer interaction technology to enhance and revolutionize the world’s workforce.

Jonathan Sackier

Dr. Sackier is a medical robotics maverick who played a key role in developing AESOP (Automated Endoscopic System for Optimal Positioning), which received FDA clearance in 1994 and became the first robot to assist in minimally invasive surgery.

Vasileios K. Katsaros

Epilepsy, EEG, MEG, and NeuroRadiology Subcommittee SBMT 2023- 2024
Neuroradiologist, Athens, Greece Director of the Department of Advanced Imaging Modalities General Anti-Cancer and Oncological Hospital of Athens